stock market
Novartis exec sold off shares before Zolgensma data scandal was revealed
August 19, 2019Sales and Marketing AveXis, Novartis, Shares, Zolgensma, pharma, stock market
An unnamed Novartis executive sold 925,400 Swiss francs (£778,665) worth of shares in the firm just weeks before the FDA …
Pharma stocks soar after US midterm elections
November 8, 2018Business Services, Manufacturing and Production Shares, Stock, Trump, biotech, pharma, stock market
Despite the threat of a bipartisan pricing plan, pharma stocks have soared after the announcement of the results of the …
Realm Therapeutics shares halved after failure of Phase 2 study
August 15, 2018Research and Development London, Shares, atopic dermatitis, phase 2, stock market
Shares in the London-listed Realm Therapeutics plummeted on Monday after the company reported that a Phase II study of the …
Immunomedics’ chief financial officer resigns, shares fall
June 22, 2016Research and Development, Sales and Marketing Immunomedics, Shares, cfo, stock market
Shares in Immunomedics (Nasdaq: IMMU) fell as much as 11% after the company said its chief financial officer Peter Pfreundschuh …
Weekly Movers: Relypsa, Titan Pharma, Allergan…
June 6, 2016Research and Development, Sales and Marketing Stock, drug trial, research, stock market
The prestigious ASCO meet is underway and results of new drug trials will be a key stock mover over the …
Illumina shares plunge as it cuts Q1 outlook
April 20, 2016Research and Development, Sales and Marketing Financial, Illumina, Share price, Shares, outlook, revenue, stock market
Shares in Illumina (Nasdaq: ILMN) plunged after the company cut its revenue estimates for the first quarter based on low …
Weekly Movers: Valeant, Depomed, Intercept Pharma, Insys Therapeutics and more…
April 18, 2016Manufacturing and Production, Research and Development, Sales and Marketing Depomed, Intercept Pharma, Relypsa, Share price, Stock Movement, Valeant, stock market
Troubles don’t seem to go away for Canada-based Valeant Pharma (NYSE: VRX) with news of a probable sale doing the …
